Searchable abstracts of presentations at key conferences in endocrinology

ea0085p92 | Thyroid | BSPED2022

Multisystem involvement in severe primary hypothyroidism

Baioumi Alaa , Kolenova Alzbeta , Avatapalle Bindu

A 10-year-old female was referred because of prolonged bleeding lasting for a week following a tooth extraction. She had menarche at the age of 9 years, and since then, she used to have regular heavy periods lasting for over two weeks every month. She had low haemoglobin, prolonged APTT and low von Willebrand antigen level. Therefore, she was diagnosed with von Willebrand disease. At the same time, she was found to have a high TSH and low free T4. She was referred to the paedi...

ea0024p4 | (1) | BSPED2010

Neonatal adrenal suppression from maternal steroid use: A retrospective case note study

Ho S , Petkar R , Avatapalle B , Coombs R

Introduction: Infants born to mothers on antenatal steroid medication may develop adrenal suppression postnatally which can be potentially life-threatening. However, the incidence is unknown and screening for at risk infants is not universal.Aim: The aim of our study was to review the outcome of infants born to mothers on antenatal steroids.Method: We retrospectively reviewed our neonatal “paediatric alerts” for mothers o...

ea0023p20 | (1) | BSPED2009

Synacthen tests in children with asthma on high dose inhaled corticosteroids

Avatapalle Hima Bindu , Sachdev Pooja , Wright Neil , Elder Charlie

Background: Adrenal suppression is a well recognised complication of inhaled corticosteroids. Committee for Safety of Medicines (CSM) guidelines (2006) recommend that children taking high dose inhaled corticosteroids (HDICS) are tested for adrenal insufficiency. Patients requiring steroid replacement require a steroid card and written advice on steroid replacement in acute illness.Aims: To determine the impact of CSM guidelines on the use of short synact...

ea0095p15 | Bone | BSPED2023

Stuve Wiedemann syndrome – case series of 3 cases

Ramalingam Bharani Anand , Avatapalle Bindu , Williams Georgina , Pryce Rebekah

Introduction: Stuve–Wiedemann Syndrome (SWS) is a rare genetic condition with autosomal recessive inheritance characterized by the association of typical facial appearances, skeletal manifestations including bowed legs and dysautonomia. Only two patients with long survival have been reported in 2001. We report three children whose periodic clinical evolution could be observed in our hospital until the age of 9 years. We report a case of SWS with associate...

ea0085oc10.6 | Oral Communications 10 | BSPED2022

A comparative study observing the association between graves’ disease and the covid-19 pandemic in children

Uppal Kamalpreet , Warner Justin , Williams Georgina , Pryce Rebekah , Hawkes Davida , Bindu Avatapalle Hima

Background: Coronavirus 2019 (Covid-19), an infectious disease caused by SARS-CoV-2 virus has been linked to autoimmunity. Graves’ disease (GD) is a common subtype of paediatric hyperthyroidism and an autoimmune condition, where antibodies stimulate the thyroid-stimulating hormone receptor on the thyroid gland to produce excess thyroid hormone. Although, paediatric GD is rare, incidence have risen before the pandemic, and this rise has accelerated since the Covid-19 pande...

ea0030p10 | (1) | BSPED2012

A case of Noonan syndrome with a SHOC2 mutation associated with cortical and trabecular osteopenia and early onset fragility fractures

Avatapalle Bindu , Padidela Raja , Clayton-Smith Jill , Freemont Tony , Burkitt-Wright Emma , Mughal Zulf

Introduction: Noonan syndrome (NS) (OMIM 163950) is an autosomal dominant clinically heterogeneous disorder characterised by multisystem involvement. Mutations in genes in the RAS/MAP signaling pathways are known to be responsible for ~70% of cases of NS. We report an infant with NS with early onset fragility fractures.Case report: A 15-month-old male infant with a history of atopic eczema, sparse hair on the scalp, slow motor development, feeding diffic...

ea0027p77 | (1) | BSPED2011

Octreotide treatment for congenital hyperinsulinism can cause hepatitis

Avatapalle Bindu , Rigby Lindsey , Patel Leena , Ehtisham Sarah , Skae Mars , Padidela Raja , Banerjee Indraneel , Clayton Peter

Introduction: Congenital hyperinsulinism (CHI) is a rare condition of dysregulated insulin secretion causing hypoglycaemia. Oral Diazoxide is used as first line therapy for CHI. In those who are Diazoxide unresponsive, subcutaneous Octreotide is used as second line treatment. Octreotide has recognised side effects of biliary stasis. Additionally, we report hepatitis as a complication of Octreotide therapy in a child with CHI.Case report: A neonate with C...

ea0027p81 | (1) | BSPED2011

An audit of diazoxide prescriptions in children with congenital hyperinsulinism: preliminary recommendations

Dimitriu Alma Iulia , Avatapalle Bindu , Rigby Lindsey , Banerjee Indraneel , Patel Leena

Introduction: Congenital hyperinsulinism (CHI) is characterised by abnormally regulated and excessive insulin secretion by pancreatic β cells. First line management includes an oral suspension of Diazoxide but a standardised formulation is not universally employed. Anecdotal evidence suggests that different formulations can alter the management of glucose levels. Lack of glucose control can lead to permanent brain damage and adversely affect neuro development.<p class...

ea0045p47 | Miscellaneous/other | BSPED2016

Longitudinal changes in bone density and body composition in post-pubertal adolescents treated with GnRH analogues in a Gender Identity Development Service

Tseretopoulou Xanthippi , Alvi Sabah , Avatapalle Bindu , Walker Jenny , Carruthers Paul , Mushtaq Talat

Introductions: Gender Identity Disorder (GID) occurs when a person’s gender identity differs from their biological sex, causing distress (gender dysphoria). GID presenting in childhood can dissipate at puberty. If it persists, they may progress to physical interventions. This involves the use of a GnRH analogue (GnRHa) for one year followed by cross sex hormones.Methods: As part of the clinical assessments, adolescents have body composition measurem...

ea0033p14 | (1) | BSPED2013

Design and validation of a severity scale for use in congenital hyperinsulinism

Most Jessica , Mohamed Zainab , Avatapalle Hima Bindu , Ehtisham Sarah , Foster Peter , Stevens Adam , Cosgrove Karen E , Dunne Mark J , Banerjee Indraneel , Clayton Peter E

Introduction: Congenital hyperinsulinism (CHI) is an important cause of hypoglycaemia in infancy requiring intensive medical and surgical support. Carbohydrate requirement (CHO) represents a simple index of severity but does not predict the failure of medical treatment and hence the requirement for pancreatectomy.Aims: To design and validate a severity tool for use in early onset CHI patients.Methods: To design the Manchester CHI s...